Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size for therapeutics in attention deficit hyperactivity disorder (adhd) has seen a robust growth in the past few years. It is set to expand from $13.21 billion in 2024 to hit $13.97 billion in 2025, marking a compound annual growth rate (CAGR) of 5.7%. The historical growth in this field is due to factors like increased awareness and diagnostic screenings, a rising number of ADHD cases, advancements in treatment methods, development in healthcare infrastructure, and the broadening of health insurance coverage.
In the coming years, the market for therapeutics in attention deficit hyperactivity disorder (ADHD) is forecasted to experience significant expansion, reaching a valuation of $17 billion in 2029, flaunting a compound annual growth rate (CAGR) of 5.0%. This projected growth in the specified period can be credited to factors such as genetic research and personalized medicine, a rise in mental health consciousness, mental health drives on a global and national level, the growth of telehealth, and the incorporation of behavioral therapies. The prediction period is also likely to witness an array of trends like advancements in treatment technology, research and development efforts, inclusion of digital therapeutics, adoption of precision medicine techniques and novel developments in drug delivery systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14042&type=smp
What Are the Core Market Drivers Propelling Growth in the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry?
The growth of the attention-deficit hyperactivity disorder (ADHD) therapeutic market is anticipated to be fueled by the escalating incidence of ADHD. The surging incidence refers to a rising number of people diagnosed with this neurodevelopmental disorder. ADHD therapeutics are designed to address the complex nature of the disorder with the goal to enhance symptom control, functional disability, quality of life, and general well-being for those living with ADHD. For example, as reported by the Guardian, a US-based news publisher, in January 2023, around 170,000 identified patients were recommended ADHD therapeutics in 2022, marking a 20.4% surge from the 141,000 diagnosed patients in the same span in 2021. Thus, the escalating incidence of ADHD is boosting the growth of the ADHD therapeutic market.
How Is the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segmented?
The attention deficit hyperactivity disorder (adhd) therapeutics market covered in this report is segmented –
1) By Drug Type: Stimulants, Non-Stimulants
2) By Psychotherapy: Behavior Therapy, Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Family Therapy
3) By Age Group: Pediatric And Adolescent, Adult
4) By Distribution Channel: Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, E-Commerce
Subsegments:
1) By Stimulants: Amphetamine-Based Stimulants, Methylphenidate-Based Stimulants
2) By Non-Stimulants: Atomoxetine, Guanfacine, Clonidine
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=14042&type=smp
Which Regions Are Driving the Next Phase of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Growth?
North America was the largest region in the attention deficit hyperactivity disorder (ADHD) therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry?
Key players in the ADHD therapeutics market are increasingly putting their attention towards the creation of digital advancements such as Endeavor over-the-counter (OTC) versions of digital therapeutics for ADHD. This move is due to the escalating demand for digital solutions and a surge in the need for remote healthcare. Digital therapeutics are evidence-based treatments propelled by high-grade software that aim to prevent, manage, or cure medical disorders or diseases. These treatments can be used standalone or with conventional medical methods. For example, in June 2023, Akili, an American digital health firm, unveiled an over-the-counter (OTC) version of its videogame-centered digital therapy for adults with ADHD named EndeavorOTC. This OTC version aims to enhance attention, time managing, and organizing skills in adults. This followed the positive outcome from Akili’s FDA-approved prescription video game treatment, EndeavorRx, for children with ADHD. The OTC alternative offers adults a non-drug method to control their ADHD symptoms.
View the full report here:
How Is the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Defined and What Are Its Core Parameters?
Attention deficit hyperactivity disorder (ADHD) therapeutics refers to the range of treatments and interventions aimed at managing the symptoms and improving the functioning of individuals diagnosed with ADHD. ADHD is a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity that significantly interfere with daily functioning and development. The primary objective of ADHD therapeutics is to enhance attention, impulse control, and overall functioning in daily activities, thereby improving the quality of life for individuals affected by ADHD.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14042
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model